News | August 15, 2024
Evonik expands its formulation capabilities for lipid nanoparticles
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Subscribe To Our Newsletter & Stay Updated
